241 related articles for article (PubMed ID: 19242824)
1. Impact of nucleotide excision repair ERCC2 and base excision repair APEX1 genes polymorphism and its association with recurrence after adjuvant BCG immunotherapy in bladder cancer patients of North India.
Gangawar R; Ahirwar D; Mandhani A; Mittal RD
Med Oncol; 2010 Jun; 27(2):159-66. PubMed ID: 19242824
[TBL] [Abstract][Full Text] [Related]
2. Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.
Gu J; Zhao H; Dinney CP; Zhu Y; Leibovici D; Bermejo CE; Grossman HB; Wu X
Clin Cancer Res; 2005 Feb; 11(4):1408-15. PubMed ID: 15746040
[TBL] [Abstract][Full Text] [Related]
3. Influence of XPD and APE1 DNA repair gene polymorphism on bladder cancer susceptibility in north India.
Gangwar R; Ahirwar D; Mandhani A; Mittal RD
Urology; 2009 Mar; 73(3):675-80. PubMed ID: 19041121
[TBL] [Abstract][Full Text] [Related]
4. IL-8 -251 T > A polymorphism is associated with bladder cancer susceptibility and outcome after BCG immunotherapy in a northern Indian cohort.
Ahirwar DK; Mandhani A; Mittal RD
Arch Med Res; 2010 Feb; 41(2):97-103. PubMed ID: 20470938
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of the human NRAMP1 gene are associated with response to bacillus Calmette-Guerin immunotherapy for superficial bladder cancer.
Decobert M; Larue H; Bergeron A; Harel F; Pfister C; Rousseau F; Lacombe L; Fradet Y
J Urol; 2006 Apr; 175(4):1506-11. PubMed ID: 16516037
[TBL] [Abstract][Full Text] [Related]
6. Association of Bacillus Calmette-Guerin shortages with bladder cancer recurrence: A single-center retrospective study.
Lee S; Lim B; You D; Hong B; Hong JH; Kim CS; Ahn H; Jeong IG
Urol Oncol; 2020 Nov; 38(11):851.e11-851.e17. PubMed ID: 32800440
[TBL] [Abstract][Full Text] [Related]
7. Complex association between ERCC2 gene polymorphisms, gender, smoking and the susceptibility to bladder cancer: a meta-analysis.
Wu Y; Yang Y
Tumour Biol; 2014 Jun; 35(6):5245-57. PubMed ID: 24504678
[TBL] [Abstract][Full Text] [Related]
8. FASL polymorphism is associated with response to bacillus Calmette-Guérin immunotherapy in bladder cancer.
Lima L; Ferreira JA; Tavares A; Oliveira D; Morais A; Videira PA; Medeiros R; Santos L
Urol Oncol; 2014 Jan; 32(1):44.e1-7. PubMed ID: 23948181
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in DNA repair genes (APEX1, XPD, XRCC1 and XRCC3) and risk of preeclampsia in a Mexican mestizo population.
Sandoval-Carrillo A; Méndez-Hernández EM; Vazquez-Alaniz F; Aguilar-Durán M; Téllez-Valencia A; Barraza-Salas M; Castellanos-Juárez FX; Llave-León OL; Salas-Pacheco JM
Int J Mol Sci; 2014 Mar; 15(3):4273-83. PubMed ID: 24619222
[TBL] [Abstract][Full Text] [Related]
10. Association of polymorphisms in oxidative stress genes with clinical outcomes for bladder cancer treated with Bacillus Calmette-Guérin.
Wei H; Kamat A; Chen M; Ke HL; Chang DW; Yin J; Grossman HB; Dinney CP; Wu X
PLoS One; 2012; 7(6):e38533. PubMed ID: 22701660
[TBL] [Abstract][Full Text] [Related]
11. The Role of Vitamin D Receptor Polymorphisms in Predicting the Response to Therapy for Nonmuscle Invasive Bladder Carcinoma.
Wang Z; Lim YK; Lim HCC; Chan YH; Ngiam N; Raman Nee Mani L; Esuvaranathan K; Ng CF; Teoh J; Chan E; Mahendran R; Chiong E
J Urol; 2018 Oct; 200(4):737-742. PubMed ID: 29857077
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk.
De Ruyck K; Szaumkessel M; De Rudder I; Dehoorne A; Vral A; Claes K; Velghe A; Van Meerbeeck J; Thierens H
Mutat Res; 2007 Jul; 631(2):101-10. PubMed ID: 17531525
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism in autophagy gene ATG2B is not associated with bladder cancer recurrence after intravesical Bacillus Calmette-Guerin (BCG) immunotherapy in Asian patients.
Zang Z; Lim YK; Chan YH; Raman L; Esuvaranathan K; Chiong E; Mahendran R
Urol Oncol; 2021 Apr; 39(4):238.e1-238.e7. PubMed ID: 33250346
[TBL] [Abstract][Full Text] [Related]
14. Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival.
Salimzadeh H; Lindskog EB; Gustavsson B; Wettergren Y; Ljungman D
BMC Cancer; 2020 May; 20(1):409. PubMed ID: 32397974
[TBL] [Abstract][Full Text] [Related]
15. The role of functional polymorphisms in immune response genes as biomarkers of bacille Calmette-Guérin (BCG) immunotherapy outcome in bladder cancer: establishment of a predictive profile in a Southern Europe population.
Lima L; Oliveira D; Ferreira JA; Tavares A; Cruz R; Medeiros R; Santos L
BJU Int; 2015 Nov; 116(5):753-63. PubMed ID: 24931268
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in XRCC1, ERCC2, and ERCC3 DNA repair genes, CYP1A1 xenobiotic metabolism gene, and tobacco are associated with bladder cancer susceptibility in Tunisian population.
Feki-Tounsi M; Khlifi R; Louati I; Fourati M; Mhiri MN; Hamza-Chaffai A; Rebai A
Environ Sci Pollut Res Int; 2017 Oct; 24(28):22476-22484. PubMed ID: 28803404
[TBL] [Abstract][Full Text] [Related]
17. Anti- and proinflammatory cytokine gene polymorphism and genetic predisposition: association with smoking, tumor stage and grade, and bacillus Calmette-Guérin immunotherapy in bladder cancer.
Ahirwar D; Kesarwani P; Manchanda PK; Mandhani A; Mittal RD
Cancer Genet Cytogenet; 2008 Jul; 184(1):1-8. PubMed ID: 18558283
[TBL] [Abstract][Full Text] [Related]
18. NRAMP1 and hGPX1 gene polymorphism and response to bacillus Calmette-Guérin therapy for bladder cancer.
Chiong E; Kesavan A; Mahendran R; Chan YH; Sng JH; Lim YK; Kamaraj R; Tan TM; Esuvaranathan K
Eur Urol; 2011 Mar; 59(3):430-7. PubMed ID: 21163569
[TBL] [Abstract][Full Text] [Related]
19. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
[TBL] [Abstract][Full Text] [Related]
20. Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India.
Sreeja L; Syamala VS; Syamala V; Hariharan S; Raveendran PB; Vijayalekshmi RV; Madhavan J; Ankathil R
J Cancer Res Clin Oncol; 2008 Jun; 134(6):645-52. PubMed ID: 17952468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
